Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A11018 | 31080822 | Biomed Res Int | Diabetes Mellitus and Risk of Hepatic Fibrosis/Cirrhosis. | 2019 | Details |
| A11021 | 31080056 | Ann Hepatol | Non-alcoholic fatty liver disease and neurological defects. | 2019 | Details |
| A11034 | 31075323 | J Hepatol | The beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content. | 2019 | Details |
| A11057 | 31064058 | Int J Mol Sci | Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A11075 | 31055550 | Wiad Lek | Comorbidity severity index as a new tool for assessment of co-existing diseases in patients with non-alcoholic fatty liver disease at the carbohydrate metabolism disorder background and concomitant subclinical hypothyroidism. | 2019 | Details |
| A11081 | 31054837 | Prim Care Diabetes | Association of non-alcoholic fatty liver disease with microvascular complications of type 2 diabetes. | 2019 | Details |
| A11090 | 31046673 | Mol Med | Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes. | 2019 | Details |
| A11093 | 31045779 | Medicine (Baltimore) | Presence of diabetic retinopathy is lower in type 2 diabetic patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A11096 | 31044315 | Curr Diab Rep | Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A11113 | 31035998 | BMC Med | Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity. | 2019 | Details |
| A11135 | 31027093 | Medicine (Baltimore) | Glycogenic hepatopathy as an unusual etiology of deranged liver function in a patient with type 1 diabetes: A case report. | 2019 | Details |
| A11139 | 31025557 | Adv Clin Exp Med | Clinical outcomes of non-alcoholic fatty liver disease: Polish-case control study. | 2019 | Details |
| A11154 | 31020720 | Exp Physiol | Combined treatment of dipeptidyl peptidase-4 inhibitor and exercise training improves lipid profile in KK/Ta mice. | 2019 | Details |
| A11155 | 31019719 | Glob Health Epidemiol Genom | Non-alcoholic fatty liver disease in Africa: a hidden danger. | 2019 | Details |
| A11161 | 31016455 | Obes Surg | The HAALT Non-invasive Scoring System for NAFLD in Obesity. | 2019 | Details |
| A11165 | 31013454 | Metab Syndr Relat Disord | In New-Onset Diabetes Mellitus, Metformin Reduces Fat Accumulation in the Liver, But Not in the Pancreas or Pericardium. | 2019 | Details |
| A11167 | 31013265 | Med Sci Monit | Transcriptional Regulation of Early Growth Response Gene-1 (EGR1) is Associated with Progression of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients with Insulin Resistance. | 2019 | Details |
| A11168 | 31013163 | Endocr Pract | FATTY KIDNEY DISEASE: A NEW RENAL AND ENDOCRINE CLINICAL ENTITY? DESCRIBING THE ROLE OF THE KIDNEY IN OBESITY, METABOLIC SYNDROME, AND TYPE 2 DIABETES. | 2019 | Details |
| A11179 | 31009793 | Clin Gastroenterol Hepatol | Risk Factors for Severe Liver Disease in Patients With Type 2 Diabetes. | 2019 | Details |
| A11192 | 31004828 | Cell Mol Gastroenterol Hepatol | Metabolic Targets in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11204 | 31000862 | J Pak Med Assoc | Expert Opinion: Use of sodium glucose co-transporter type-2 inhibitors in South Asian population -The Pakistan perspective. | 2019 | Details |
| A11206 | 30999770 | Scand J Gastroenterol | Characteristics and risk factors for recurrence of nonalcoholic steatohepatitis following liver transplantation. | 2019 | Details |
| A11207 | 30999670 | Cells | Therapeutic Application of Micellar Solubilized Xanthohumol in a Western-Type Diet-Induced Mouse Model of Obesity, Diabetes and Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A11209 | 30998190 | Ann Biol Clin (Paris) | [Incretins-adipocytokines interactions in type 2 diabetic subjects with or without non-alcoholic fatty liver disease: interest of GLP-1 (glucagon-like peptide-1) as a modulating biomarker]. | 2019 | Details |
| A11212 | 30993937 | Diabetes Metab J | Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment. | 2019 | Details |
| A11215 | 30993553 | Clin Drug Investig | Effect of Sodium Glucose Co-Transporter 2 Inhibitors on Liver Fat Mass and Body Composition in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. | 2019 | Details |
| A11240 | 30978266 | PLoS One | Non-alcoholic fatty liver disease and pregnancy complications among Sri Lankan women: A cross sectional analytical study. | 2019 | Details |
| A11250 | 30973968 | Br J Clin Pharmacol | Hepatic exposure of metformin in patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A11262 | 30970431 | Gut Liver | Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus. | 2019 | Details |
| A11264 | 30969285 | Food Funct | Systematic investigation of the mechanism of Cichorium glandulosum on type 2 diabetes mellitus accompanied with non-alcoholic fatty liver rats. | 2019 | Details |
| A11267 | 30968536 | Liver Int | Prescription of statins in suspected non-alcoholic fatty liver disease and high cardiovascular risk, a population-based study. | 2019 | Details |
| A11269 | 30965381 | Z Gastroenterol | Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments. | 2019 | Details |
| A11273 | 30964704 | Am J Physiol Endocrinol Metab | Role of exercise-induced hepatokines in metabolic disorders. | 2019 | Details |
| A11277 | 30962478 | Nat Commun | Hepatic arginase 2 (Arg2) is sufficient to convey the therapeutic metabolic effects of fasting. | 2019 | Details |
| A11279 | 30961499 | Curr Vasc Pharmacol | Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block. | 2020 | Details |
| A11284 | 30958562 | Histol Histopathol | Modulatory effect of inulin with soya isoflavones on plasma lipid profile and liver SCD-18 index in rats with induced type-2 diabetes mellitus. | 2019 | Details |
| A11307 | 30945694 | J Genet | Genetics of nonalcoholic fatty liver disease in Asian populations. | 2019 | Details |
| A11312 | 30943987 | J Transl Med | Experimental non-alcoholic steatohepatitis in Göttingen Minipigs: consequences of high fat-fructose-cholesterol diet and diabetes. | 2019 | Details |
| A11313 | 30943218 | PLoS One | Lipidomic and transcriptomic analysis of western diet-induced nonalcoholic steatohepatitis (NASH) in female Ldlr -/- mice. | 2019 | Details |
| A11318 | 30940491 | Nutr Metab Cardiovasc Dis | Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese. | 2019 | Details |
| A11328 | 30936141 | Diabetes | A Peripheral Blood DNA Methylation Signature of Hepatic Fat Reveals a Potential Causal Pathway for Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11329 | 30935932 | Gastrointest Endosc | Duodenal mucosal resurfacing: proof-of-concept, procedural development, and initial implementation in the clinical setting. | 2019 | Details |
| A11344 | 30929337 | Zhonghua Gan Zang Bing Za Zhi | [Analysis of influencing factors and causes of death in elderly residents with non-alcoholic fatty liver disease]. | 2019 | Details |
| A11346 | 30928918 | BMJ Open | Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials. | 2019 | Details |
| A11350 | 30927369 | Br J Pharmacol | Oral administration of a new HRI activator as a new strategy to improve high-fat-diet-induced glucose intolerance, hepatic steatosis, and hypertriglyceridaemia through FGF21. | 2019 | Details |
| A11351 | 30927288 | Clin Transplant | The impact of post-transplant diabetes mellitus on liver transplant outcomes. | 2019 | Details |
| A11359 | 30923554 | Cell Mol Biol Lett | The Pro12Ala polymorphism in the PPAR-γ2 gene is not associated with an increased risk of NAFLD in Iranian patients with type 2 diabetes mellitus. | 2019 | Details |
| A11362 | 30922067 | Cell Transplant | Association between Non-Alcoholic Fatty Liver Disease and Intracerebral Hemorrhage. | 2019 | Details |
| A11366 | 30920583 | Endocr Rev | The Liver-α-Cell Axis and Type 2 Diabetes. | 2019 | Details |
| A11373 | 30919338 | Adv Exp Med Biol | Circular RNAs as Potential Biomarkers and Therapeutic Targets for Metabolic Diseases. | 2019 | Details |
| A11374 | 30919335 | Adv Exp Med Biol | miRNA Regulation of Glucose and Lipid Metabolism in Relation to Diabetes and Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A11376 | 30919112 | Heart Vessels | High Fib4 index in patients with suspected NASH is associated with elevation of chymase-dependent angiotensin II-forming activity in circulating mononuclear leucocytes. | 2019 | Details |
| A11384 | 30917546 | Nutrients | Non-Alcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: Role of Circulating Branched-Chain Amino Acids. | 2019 | Details |
| A11401 | 30912255 | Liver Int | Association of adipokines with hepatic steatosis and fibrosis in chronic hepatitis B patients on long-term nucleoside analogue. | 2019 | Details |
| A11407 | 30907181 | Scand J Gastroenterol | Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD). | 2019 | Details |
| A11421 | 30901317 | Rom J Intern Med | Non-alcoholic fatty pancreas disease - practices for clinicians. | 2019 | Details |
| A11437 | 30896648 | Medicine (Baltimore) | A randomized controlled trial on the effectiveness of 8-week high-intensity interval exercise on intrahepatic triglycerides, visceral lipids, and health-related quality of life in diabetic obese patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A11441 | 30893108 | Curr Opin Lipidol | Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell? | 2019 | Details |
| A11450 | 30889791 | Medicines (Basel) | The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11463 | 30885145 | BMC Gastroenterol | The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose. | 2019 | Details |
| A11467 | 30883738 | J Physiol | Challenging metabolic tissues with fructose: tissue-specific and sex-specific responses. | 2019 | Details |
| A11474 | 30881345 | Front Endocrinol (Lausanne) | Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease. | 2019 | Details |
| A11480 | 30878016 | J Endocrinol | Short-term strength training reduces gluconeogenesis and NAFLD in obese mice. | 2019 | Details |
| A11481 | 30877708 | Diabetes Metab J | Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus. | 2019 | Details |
| A11501 | 30868786 | J Ayub Med Coll Abbottabad | Association Of Non-Alcoholic Fatty Liver Disease With Serum Uric Acid. | 2019 | Details |
| A11511 | 30865013 | Am J Gastroenterol | Physical Activity, Fatty Liver, and Glucose Metabolism Over the Life Course: The Lifelines Cohort. | 2019 | Details |
| A11529 | 30855277 | J Clin Invest | Resolving inflammation in nonalcoholic steatohepatitis. | 2019 | Details |
| A11544 | 30850262 | Trends Endocrinol Metab | Calcium Signaling As a Therapeutic Target for Liver Steatosis. | 2019 | Details |
| A11549 | 30848827 | J Clin Endocrinol Metab | Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes. | 2019 | Details |
| A11550 | 30847862 | J Endocrinol Invest | Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes. | 2019 | Details |
| A11551 | 30847736 | Curr Obes Rep | Changes in Bile Acid Metabolism, Transport, and Signaling as Central Drivers for Metabolic Improvements After Bariatric Surgery. | 2019 | Details |
| A11568 | 30836450 | Aliment Pharmacol Ther | Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non-alcoholic fatty liver disease; the importance of an elevated mean platelet volume. | 2019 | Details |
| A11585 | 30829446 | Liver Int | Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis. | 2019 | Details |
| A11588 | 30827925 | Clin Res Hepatol Gastroenterol | Increased mortality in non-alcoholic fatty liver disease with chronic kidney disease is explained by metabolic comorbidities. | 2019 | Details |
| A11589 | 30827909 | Endocrinol Diabetes Nutr (Engl Ed) | Document on a comprehensive approach to type 2 diabetes mellitus. | 2019 | Details |
| A11622 | 30815083 | AMIA Annu Symp Proc | Application of Machine Learning Methods to Predict Non-Alcoholic Steatohepatitis (NASH) in Non-Alcoholic Fatty Liver (NAFL) Patients. | 2018 | Details |
| A11623 | 30814508 | Nat Commun | Hepatic Sdf2l1 controls feeding-induced ER stress and regulates metabolism. | 2019 | Details |
| A11633 | 30810330 | Rev Esp Enferm Dig | Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD). | 2019 | Details |
| A11635 | 30810254 | Int J Clin Pract | Impact of dapagliflozin, an SGLT2 inhibitor, on serum levels of soluble dipeptidyl peptidase-4 in patients with type 2 diabetes and non-alcoholic fatty liver disease. | 2019 | Details |
| A11652 | 30803948 | BMJ Open | Post hoc analyses of surrogate markers of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis in patients with type 2 diabetes in a digitally supported continuous care intervention: an open-label, non-randomised controlled study. | 2019 | Details |
| A11654 | 30803094 | Microcirculation | Multi-domain analysis of microvascular flow motion dynamics in NAFLD. | 2019 | Details |
| A11655 | 30802917 | Exp Clin Endocrinol Diabetes | Progression of Albuminuria Among Patients with Type 1 Diabetes Mellitus: A Long Term Observational Follow-up Study. | 2019 | Details |
| A11678 | 30793550 | Diabetes Metab J | Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis. | 2019 | Details |
| A11679 | 30792450 | Sci Rep | Discovery of ((1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl)ureidyl derivatives as selective non-steroidal agonists of the G-protein coupled bile acid receptor-1. | 2019 | Details |
| A11684 | 30791778 | Expert Rev Gastroenterol Hepatol | Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times. | 2018 | Details |
| A11697 | 30788048 | World J Diabetes | SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A systematic review. | 2019 | Details |
| A11698 | 30787925 | Front Immunol | The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity. | 2019 | Details |
| A11700 | 30787473 | Eur J Clin Nutr | The role of dietary sugars in health: molecular composition or just calories? | 2019 | Details |
| A11715 | 30779990 | Clin Gastroenterol Hepatol | Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic Steatohepatitis. | 2019 | Details |
| A11728 | 30774403 | Diabetes Metab Syndr Obes | The fatty liver index, a simple and useful predictor of metabolic syndrome: analysis of the Korea National Health and Nutrition Examination Survey 2010-2011. | 2019 | Details |
| A11730 | 30773868 | Zhen Ci Yan Jiu | [Progress of researches on acupuncture treatment of diseases by regulating endoplasmic reticulum stress]. | 2019 | Details |
| A11741 | 30770030 | Diab Vasc Dis Res | Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift. | 2019 | Details |
| A11748 | 30767421 | Diabetes Metab Res Rev | The association between pancreas steatosis and metabolic syndrome: A systematic review and meta-analysis. | 2019 | Details |
| A11754 | 30765935 | J Clin Exp Hepatol | Renal Dysfunction in Patients With Nonalcoholic Fatty Liver Disease is Related to the Presence of Diabetes Mellitus and Severity of Liver Disease. | 2017 | Details |
| A11758 | 30763699 | Diabetes Metab | Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease. | 2019 | Details |
| A11769 | 30758417 | Rev Assoc Med Bras (1992) | The efficacy of saxagliptin in T2DM patients with non-alcoholic fatty liver disease: preliminary data. | 2019 | Details |
| A11772 | 30756471 | J Dig Dis | Circulating miR-29b positively correlates with non-alcoholic fatty liver disease in a Chinese population. | 2019 | Details |
| A11773 | 30755994 | Eur J Case Rep Intern Med | Mauriac Syndrome: A Rare Complication of Type 1 Diabetes Mellitus. | 2018 | Details |
| A11785 | 30745809 | Int J Med Sci | Non-alcoholic fatty liver disease is associated with low-grade albuminuria in men without diabetes mellitus. | 2019 | Details |
| A11792 | 30740871 | Diabetes Metab Res Rev | Metabolic effects and safety of Roux-en-Y gastric bypass surgery vs. conventional medication in obese Chinese patients with type 2 diabetes. | 2019 | Details |